References
- Moheno P Pfleiderer W DiPasquale AG Rheingold AL Fuchs D Cytokine and IDO metabolite changes effected by calcium pterin during inhibition of MDA-MB-231 xenograph tumors in nude mice Int J Pharm 2008 355 1–2 238 248 18272305
- Moheno P Morrey J Fuchs D Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice J Transl Med 2010 8 32 20356392
- Sakala IG Blazevic A Moheno P Hoft DF Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1beta and nitric oxide Unpublished manuscript 2011
- Moheno P Pfleiderer W Fuchs D Plasma cytokine concentration changes induced by the antitumor agents dipterinyl calcium pentahydrate (DCP) and related calcium pterins Immunobiology 2009 214 2 135 141 19167992
- Kolb H Mandrup-Poulsen T An immune origin of type 2 diabetes? Diabetologia 2005 48 6 1038 1050 15864529
- Kristiansen OP Mandrup-Poulsen T Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 2005 54 Suppl 2 S114 S124 16306329
- Gallou-Kabani C Vigé A Gross MS C57BL/6 J and A/J mice fed a high-fat diet delineate components of metabolic syndrome Obesity (Silver Spring) 2007 15 8 1996 2005 17712117
- Widner B Werner ER Schennach H Wachter H Fuchs D Simultaneous measurement of serum tryptophan and kynurenine by HPLC Clin Chem 1997 43 12 2424 2426 9439467
- Smith MJ Garrett RH A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation Inflamm Res 2005 54 11 435 450 16307217
- Gill DS Barradas MA Fonseca VA Dandona P Plasma histamine concentrations are elevated in patients with diabetes mellitus and peripheral vascular disease Metabolism 1989 38 3 243 247 2918844
- Kaufman LD Philen RM Tryptophan: current status and future trends for oral administration Drug Saf 1993 8 2 89 98 8452659